A 64-year-old ex-smoker with COPD complains of increasing breathlessness and cough. His current treatment includes a short-acting beta-2 agonist (SABA) as needed. His FEV1 is 55% of predicted and he has frequent exacerbations. Which therapy is indicated next for maintenance?